AMSTERDAM, Netherlands, July 26, 2010 (GLOBE NEWSWIRE) -- Presbia, a leading medical device company that has developed a corneal inlay optical surgical solution for presbyopia, announced today that renowned refractive surgeon Dr. Ronald R. Krueger of Cleveland Clinic has joined its Medical Advisory Board. Dr. Krueger brings more than 26 years of experience in refractive surgery to the advisory board, which is chaired by Prof. Ioannis Pallikaris, M.D., widely regarded as the "father" of LASIK surgery.
Dr. Krueger joins the Presbia Board as the company pursues additional regulatory approvals for its Flexivue Microlensä--a safe, effective, and reversible solution to treat presbyopia that eliminates adults' need for reading glasses.
Dr. Krueger, Medical Director of the Cole Eye Institute at Lerner College of Medicine at Case Western Reserve University, has performed over 15,000 refractive surgery procedures and has authored hundreds of peer reviewed manuscripts, abstracts, book chapters and trade journal articles.
"I believe Presbia's solution from both the patients' and doctors' perspective is setting the standard for implantable, removable lenses to treat the loss of near vision in a growing population of aging adults around the world," Dr. Krueger said. "The Flexivue Microlensa product and procedure employs the superior precision of the femtosecond laser and utilizes among the most advanced technology available."
"The addition of Dr. Krueger to our distinguished Medical Advisory Board significantly deepens the expertise of our team," said Prof. Pallikaris. "His extensive knowledge and experience in refractive surgery will enhance our ability to bring our proprietary lens to the growing presbyopic population."
In addition to serving as the Medical Director of the Department of Refractive Surgery at the Cleveland Clinic Cole Eye Institute since 1998, Dr. Krueger has recently become a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He was a former Secretary of Education and board member of the International Society of Refractive Surgery prior to its merger with the American Academy of Ophthalmology, and now serves in the executive committee and as Program Committee Chairman of the new ISRS/AAO. For more than 15 years, Dr. Krueger has served as the Associate Editor at the Journal of Refractive Surgery, and he has lectured on refractive surgery in more than 40 countries. Dr. Krueger earned his Bachelor of Science in Electrical Engineering at Rutgers University in New Jersey, Master of Science in Bioengineering from the University of Washington in Seattle, and medical degree from the University of Medicine and Dentistry of New Jersey.
"Dr. Krueger's role on our Medical Advisory Board will prove valuable as we move forward with our plans for the Flexivue Microlensä to obtain further regulatory approvals, continue to advance its widespread commercialization, as well as assist us in providing a comprehensive solution for presbyopia to the large and growing population it affects," said Vladimir Feingold, Chief Technology Officer of Presbia. "His distinguished career is rich with experience in the field of refractive surgery."
About Presbia's Flexivue Microlens™
Presbia's Flexivue Microlens™ solution involves implanting a 3mm lens, approximately 15 microns in edge thickness, in the corneal stroma of the patient's non-dominant eye. Using Presbia's proprietary insertion tool, the lens is placed in a pocket created in the cornea by a femtosecond laser. The lens may stay in place permanently, or can be easily removed and/or replaced if the patient's presbyopia advances and a stronger prescription is required. The less than 10-minute procedure requires no general anesthesia, and the patient's visual recovery takes only a couple of days. Since the Flexivue Microlens™ solution utilizes standard equipment and requires minimal additional training, the procedure requires no significant capital investment by the surgeon's practice.
An animated video of the procedure is available at www.presbia.com.
Presbia is a leading ophthalmic-device company focused on the development of solutions for presbyopia, the age-related loss of the ability to read or focus on near objects. Chief among these approaches is the Presbia Flexivue Microlens™, a 3mm-diameter lens implanted using femtosecond laser technology. Further information is available at www.presbia.com.
Note: The Flexivue Microlens™ and related medical procedures are not available in the United States and have not been evaluated or approved by the U.S. Food and Drug Administration.
CONTACT: Mendel Communications Sarah Troutt 212-397-1030 email@example.com